ライフサイエンスコーパス: polyomavirus middle T antigen

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 mouse mammary tumor cells transformed by the polyomavirus middle T antigen.

2 a mouse mammary tumor virus promoter-driven polyomavirus middle T antigen, a tumor in which beta1-in

3 Mammary tumors caused by transgenic polyomavirus middle T antigen, activated Neu(Erbb2), or

4 The role of polyomavirus middle T antigen-activated PI 3-kinase in a

5 phosphoinositide 3-kinase, protein kinase C, polyomavirus middle-T antigen and Cdc25), and are implic

6 Polyomavirus middle T antigen does not overcome p53-medi

7 ntisense-mediated inhibition of TGF-beta1 in polyomavirus middle T antigen-expressing tumor cells als

8 Circulating polyomavirus middle T antigen-expressing tumor cells did

9 In addition, mammary gland tumors induced by polyomavirus middle T antigen in JNK2(-/-) mice were mor

10 eu mice), but not in mice overexpressing the polyomavirus middle T antigen in mammary epithelium (MMT

11 expression of septin 9 (Sept9), not only in polyomavirus middle T antigen-induced, but in a wide var

12 Polyomavirus middle T antigen is phosphorylated on sever

13 ased mammary tumorigenesis in ovariectomized polyomavirus middle T-antigen mice.

14 Polyomavirus middle T antigen (MT) is phosphorylated on

15 ic form of protein phosphatase 2A (PP2A) and polyomavirus middle T antigen (MT) is required for the s

16 Moreover, whereas the genesis of polyomavirus middle T antigen (MT)-driven mammary cancer

17 have used as models transgenes encoding the polyomavirus middle T antigen (PVMT) and the T antigens

18 The polyomavirus middle T antigen (PyMT) oncogene activates

19 keratin 18 gene to conditionally express the polyomavirus middle T antigen (PyMT) oncogene in simple

20 and mutated forms of oncogenic ErbB2 or the polyomavirus middle T antigen (PyMT).

21 Transgenic mice coexpressing N-cadherin and polyomavirus middle T antigen (PyVmT) in the mammary epi

22 were mated to the mouse mammary tumor virus-polyomavirus middle T antigen (PyVmT) transgenic mouse m

23 of breast cancer, including the widely used polyomavirus middle-T antigen (PyVmT) model, which provi

24 Polyomavirus middle T antigen-transformed HC11 cells exp

25 alter primary mammary tumor latency in MMTV-Polyomavirus middle T antigen transgenic mice.

26 The expression of polyomavirus middle T antigen under the control of the m

27 etastases arising in mice transgenic for the polyomavirus middle T antigen under the control of the m

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。